Market feasibility, competitive landscape, and opportunity assessment
FDA pathway identification and approval strategy
Commercial readiness and go-to-market planning
InsightX derived pathway Development and scale-up strategy aligned with US regulatory expectations
Integrated regulatory, CMC, and commercialization planning
Decision support across critical development and launch milestones
NDA, ANDA, 505(b)(2), and DMF regulatory pathways
Submission planning, regulatory writing, and filing support
FDA interaction management, including responses to agency queries
IP landscape assessment and freedom-to-operate analysis
Exclusivity and lifecycle management strategies
Alignment of regulatory and IP approaches to strengthen long-term protection
Advisory support from experienced pharmaceutical scientists and leaders
Troubleshooting complex formulation, development, and scale-up challenges
Practical insights grounded in real-world regulatory and commercialization experience
Partners
